Abstract: The present invention relates to methods of treating retinopathy, retinal ischemia and/or retinal edema comprising administering an integrin or integrin subunit antagonist, leukocyte adhesion-inducing cytokine antagonist or growth factor antagonist, a selectin antagonist or adhesion molecule antagonist.
Type:
Grant
Filed:
December 29, 1999
Date of Patent:
February 25, 2003
Assignee:
The Children's Medical Center Corporation